Hartford Financial Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
Hartford Financial Management's AZN Position: Q1 2026 in Review
Hartford Financial Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,917 shares — an estimated $352K sold.
Hartford Financial Management first reported a position in AZN in Q3 2014 and held it in 25 quarters. The position peaked at $352K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Hartford Financial Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Hartford Financial Management sold 1,917 AstraZeneca shares in Q1 2026, an estimated $352K.
- Hartford Financial Management first reported a position in AstraZeneca in Q3 2014 and held it in 25 quarters.
- Hartford Financial Management's AstraZeneca position peaked at $352K in Q4 2025.
- 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.